Ambros, Peter F.

Chromosomally integrated human herpesvirus 6: questions and answers

Pellett, P. E., Ablashi, D. V., Ambros, P. F., Agut, H., Caserta, M. T., Descamps, V., Flamand, L., Gautheret‐Dejean, A., Hall, C. B., Kamble, R. T., et al. (2012) · Reviews in Medical Virology

Cytomegalovirus and herpesvirus researchViral-associated cancers and disorders

Cited by 377

Clinical and Biologic Features Predictive of Survival After Relapse of Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project

London, W. B., Castel, V., Monclair, T., Ambros, P. F., Pearson, A. D. J., Cohn, S. L., Berthold, F., Nakagawara, A., Ladenstein, R. L., Iehara, T., et al. (2011) · Journal of Clinical Oncology

Neuroblastoma Research and TreatmentsNeurofibromatosis and Schwannoma Cases

Cited by 318

Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden

Peneder, P., Stütz, A. M., Surdez, D., Krumbholz, M., Semper, S., Chicard, M., Sheffield, N. C., Pierron, G., Lapouble, E., Tötzl, M., et al. (2021) · Nature Communications

Cancer Genomics and DiagnosticsSarcoma Diagnosis and Treatment

Cited by 200

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

Vermeulen, J., De Preter, K., Naranjo, A., Vercruysse, L., Van Roy, N., Hellemans, J., Swerts, K., Bravo, S., Scaruffi, P., Tonini, G. P., et al. (2009) · The Lancet Oncology

Neuroblastoma Research and TreatmentsNeurofibromatosis and Schwannoma Cases

Cited by 192